Jun 1, 2022
Arjan Haverhals is the CEO and President of Milestone Scientific, which is exploring how to modernize hypodermic syringe use. One application of their injection technology is for women during labor and delivery to inject the epidural needle more accurately and control the pain. Milestone is also looking at dentistry, chronic pain, neuro-surgery, and cosmetic medicine as additional opportunities to deliver more efficient, precise, and safer injections.
Arjan provides a historical perspective, "Just to give you some background information from a study from last year. It was found that even when male and female patients expressed the same amount of pain, female patients' pain is often seen as less intense and more likely to benefit from psychotherapy versus medication as compared to men's pain. And I do believe that this gender gap in healthcare could lead to bias diagnoses related to chronic pain for women and may also explain why very little has changed in the field of epidural delivery. And any way we can aid in closing that gap is a win-win."
"Now, if women go for labor and delivery these days, it is still a technology that is used stemming from the 1860s, and it is nothing more or less than a hypodermic syringe, later positioned in the medical field as the loss of resistance technique, which is a very manual, subjective way of placing the epidural needle in the epidural space. And the reason why we entered this field is a strong belief that we can solve the problems, and the associated risk factors, with this high-risk epidural analgesia procedure."
@MilestoneSciInc #CompuFlov#WomensHealth #Pregnancy #LaborandDelivery #Epidural #DuralPuncture #MedicalDevice #MedTech